Embryonic stem cells and their differentiated derivatives have a fragile immune privilege but still represent novel targets of immune attack.
Embryonic stem cells (ESCs) offer an attractive potential in cell replacement therapy and regenerative medicine because of their inherent plasticity and ability to self-renew. However, the immunological response against transplanted ESC-derived allografts requires further evaluation. In this study,...
Asıl Yazarlar: | Wu, D, Boyd, A, Wood, K |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
2008
|
Benzer Materyaller
-
Transplanting stem cells: potential targets for immune attack. Modulating the immune response against embryonic stem cell transplantation.
Yazar:: Boyd, A, ve diğerleri
Baskı/Yayın Bilgisi: (2005) -
Embryonic stem cell-derived tissues are immunogenic but their inherent immune privilege promotes the induction of tolerance.
Yazar:: Robertson, N, ve diğerleri
Baskı/Yayın Bilgisi: (2007) -
Immune privilege or privileged immunity?
Yazar:: Forrester, J, ve diğerleri
Baskı/Yayın Bilgisi: (2008) -
Immune privilege of stem cells.
Yazar:: Ichiryu, N, ve diğerleri
Baskı/Yayın Bilgisi: (2013) -
Essential amino acid depletion by embryonic stem cells as a mechanism of immune privilege
Yazar:: Ichiryu, N
Baskı/Yayın Bilgisi: (2013)